Suppr超能文献

硫酸乙酰肝素蛋白聚糖-1 是丙型肝炎病毒附着于肝细胞表面的主要受体。

Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes.

机构信息

Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, Kentucky, USA.

出版信息

J Virol. 2013 Jun;87(12):6866-75. doi: 10.1128/JVI.03475-12. Epub 2013 Apr 10.

Abstract

Our recent studies demonstrated that apolipoprotein E mediates cell attachment of hepatitis C virus (HCV) through interactions with the cell surface heparan sulfate (HS). HS is known to covalently attach to core proteins to form heparan sulfate proteoglycans (HSPGs) on the cell surface. The HSPG core proteins include the membrane-spanning syndecans (SDCs), the lycosylphosphatidylinositol-linked glypicans (GPCs), the basement membrane proteoglycan perlecan (HSPG2), and agrin. In the present study, we have profiled each of the HSPG core proteins in HCV attachment. Substantial evidence derived from our studies demonstrates that SDC1 is the major receptor protein for HCV attachment. The knockdown of SDC1 expression by small interfering RNA (siRNA)-induced gene silence resulted in a significant reduction of HCV attachment to Huh-7.5 cells and stem cell-differentiated human hepatocytes. The silence of SDC2 expression also caused a modest decrease of HCV attachment. In contrast, the siRNA-mediated knockdown of other SDCs, GPCs, HSPG2, and agrin had no effect on HCV attachment. More importantly, ectopic expression of SDC1 was able to completely restore HCV attachment to Huh-7.5 cells in which the endogenous SDC1 expression was silenced by specific siRNAs. Interestingly, mouse SDC1 is also fully functional in mediating HCV attachment when expressed in the SDC1-deficient cells, consistent with recent reports that mouse hepatocytes are also susceptible to HCV infection when expressing other key HCV receptors. Collectively, our findings demonstrate that SDC1 serves as the major receptor protein for HCV attachment to cells, providing another potential target for discovery and development of antiviral drugs against HCV.

摘要

我们最近的研究表明,载脂蛋白 E 通过与细胞表面硫酸乙酰肝素 (HS) 的相互作用介导丙型肝炎病毒 (HCV) 的细胞附着。HS 已知与核心蛋白共价结合,在细胞表面形成硫酸乙酰肝素蛋白聚糖 (HSPGs)。HSPG 核心蛋白包括跨膜连接蛋白聚糖 (SDC)、糖基磷脂酰肌醇连接的聚糖 (GPC)、基底膜蛋白聚糖 perlecan (HSPG2) 和 agrin。在本研究中,我们对 HCV 附着的每种 HSPG 核心蛋白进行了分析。我们的研究得出了大量证据,证明 SDC1 是 HCV 附着的主要受体蛋白。通过小干扰 RNA (siRNA) 诱导的基因沉默敲低 SDC1 表达导致 HCV 对 Huh-7.5 细胞和干细胞分化的人肝细胞的附着显著减少。SDC2 表达的沉默也导致 HCV 附着适度减少。相比之下,siRNA 介导的其他 SDC、GPC、HSPG2 和 agrin 的沉默对 HCV 附着没有影响。更重要的是,SDC1 的异位表达能够完全恢复 Huh-7.5 细胞中的 HCV 附着,而这些细胞中的内源性 SDC1 表达被特异性 siRNA 沉默。有趣的是,当在 SDC1 缺陷细胞中表达时,鼠 SDC1 也完全能够介导 HCV 附着,这与最近的报道一致,即当表达其他关键 HCV 受体时,鼠肝细胞也容易感染 HCV。总之,我们的发现表明 SDC1 是 HCV 附着到细胞的主要受体蛋白,为发现和开发抗 HCV 抗病毒药物提供了另一个潜在靶点。

相似文献

1
Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes.
J Virol. 2013 Jun;87(12):6866-75. doi: 10.1128/JVI.03475-12. Epub 2013 Apr 10.
4
Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.
J Virol. 2012 Jul;86(13):7256-67. doi: 10.1128/JVI.07222-11. Epub 2012 Apr 24.
6
Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
J Virol. 2015 Apr;89(7):3846-58. doi: 10.1128/JVI.03647-14. Epub 2015 Jan 21.
10
CD36 is a co-receptor for hepatitis C virus E1 protein attachment.
Sci Rep. 2016 Feb 22;6:21808. doi: 10.1038/srep21808.

引用本文的文献

1
Syndecan 2 proteoglycan serves as a hepatitis B virus cell attachment receptor.
J Virol. 2025 Jul 22;99(7):e0079625. doi: 10.1128/jvi.00796-25. Epub 2025 Jun 26.
2
Syndecan-1: a key player in health and disease.
Immunogenetics. 2024 Dec 17;77(1):9. doi: 10.1007/s00251-024-01366-4.
3
Hepatitis B virus entry, assembly, and egress.
Microbiol Mol Biol Rev. 2024 Dec 18;88(4):e0001424. doi: 10.1128/mmbr.00014-24. Epub 2024 Oct 23.
4
Global transcriptomic network analysis of the crosstalk between microbiota and cancer-related cells in the oral-gut-lung axis.
Front Cell Infect Microbiol. 2024 Aug 20;14:1425388. doi: 10.3389/fcimb.2024.1425388. eCollection 2024.
5
Biomarkers in Detection of Hepatitis C Virus Infection.
Pathogens. 2024 Apr 17;13(4):331. doi: 10.3390/pathogens13040331.
6
Apolipoprotein E and viral infection: Risks and Mechanisms.
Mol Ther Nucleic Acids. 2023 Jul 28;33:529-542. doi: 10.1016/j.omtn.2023.07.031. eCollection 2023 Sep 12.
8
Expression of glycosaminoglycans in cirrhotic liver and hepatocellular carcinoma-a pilot study including etiology.
Anal Bioanal Chem. 2022 May;414(13):3837-3846. doi: 10.1007/s00216-022-04025-3. Epub 2022 Mar 28.
9
SPOCK1 Promotes the Development of Hepatocellular Carcinoma.
Front Oncol. 2022 Feb 3;12:819883. doi: 10.3389/fonc.2022.819883. eCollection 2022.
10
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry.
Front Immunol. 2021 Dec 16;12:796855. doi: 10.3389/fimmu.2021.796855. eCollection 2021.

本文引用的文献

1
Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells.
J Virol. 2012 Nov;86(21):11919-25. doi: 10.1128/JVI.01066-12. Epub 2012 Aug 15.
3
Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.
J Virol. 2012 Jul;86(13):7256-67. doi: 10.1128/JVI.07222-11. Epub 2012 Apr 24.
5
Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.
Hepatology. 2012 Aug;56(2):484-91. doi: 10.1002/hep.25665. Epub 2012 Jul 2.
6
Modeling hepatitis C virus infection using human induced pluripotent stem cells.
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2544-8. doi: 10.1073/pnas.1121400109. Epub 2012 Jan 30.
8
Dengue virus strain DEN2 16681 utilizes a specific glycochain of syndecan-2 proteoglycan as a receptor.
J Gen Virol. 2012 Apr;93(Pt 4):761-770. doi: 10.1099/vir.0.037853-0. Epub 2011 Dec 14.
10
A genetically humanized mouse model for hepatitis C virus infection.
Nature. 2011 Jun 8;474(7350):208-11. doi: 10.1038/nature10168.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验